We are excited to share a major milestone in the advancement of our technology within the thoracic oncology field. Research presented by a team from the University of Pennsylvania and Integro Theranostics at the recent IASLC 2025 World Conference on…
The necessity for fluorescence imaging (FI) to transition from qualitative visual guidance (“the glow”) to Quantitative Fluorescence Imaging (QFI) is paramount for clinical adoption. Metrics like the Tumor-to-Background Ratio (TBR) and Contrast-to-Noise Ratio (CNR) are increasingly vital for diagnostic claims in fields like Fluorescence-Guided…
In the exciting world of molecular imaging and fluorescence-guided surgery (FGS), the ability to see tumors and tissue boundaries in real-time is revolutionary. But for this technology to move from simple visual guidance to a reliable, reimbursable clinical tool, we…